Story

Synopsys Stock Slides as Earnings Beat and Guidance Raise Fall Short of Expectations

ENTHMSVIIDZHZH-TWJAKOHI
Aug 27, 20262 min read
Synopsys Stock Slides as Earnings Beat and Guidance Raise Fall Short of Expectations
Text size
Background

Shares of Synopsys (NASDAQ: SNPS) declined in pre-market trading Thursday, falling 1.5% to $404, even after the company reported stronger-than-expected fiscal third-quarter earnings and raised its full-year guidance. The negative reaction suggests the beat-and-raise report was not enough to satisfy elevated investor expectations for the chip design software giant.

Quarterly Results Exceed Estimates

In its fiscal third-quarter 2026 report released after Wednesday's market close, Synopsys announced strong financial performance that surpassed consensus forecasts. Key figures from the report include:

  • Non-GAAP EPS: $3.91, beating the analyst consensus of $3.67.
  • Revenue: $2.477 billion, ahead of the expected $2.44 billion and representing a roughly 42% increase year-over-year.

Despite these headline beats, the stock had already fallen approximately 5% in after-hours trading Wednesday before paring some of those losses.

Guidance Fails to Inspire

Sample IUX Markets – In-articleAd

While Synopsys lifted its outlook for the full fiscal year 2026, the new guidance appeared to leave little room for the significant upside that some investors had anticipated. The company now expects full-year revenue between $9.69 billion and $9.74 billion and non-GAAP EPS in the range of $15.04 to $15.10, both above its prior forecasts.

The market's muted response mirrors the reaction to the company's second-quarter results in May, when shares also fell following a solid report. The stock's decline on Thursday came amid a broader market rally, with the Nasdaq Composite up 1.1% and the S&P 500 rising 0.5%, highlighting its underperformance.

Analyst Caution and Market Context

Heading into the earnings announcement, some Wall Street analysts had already signaled caution. Morgan Stanley had trimmed its price target on Synopsys to $500 from $525, and Wells Fargo had lowered its target to $450 from $535, with both firms maintaining an Equal Weight rating.

Even with the post-earnings slide, the stock remains significantly below its 52-week high of $615.79. Investors may now be looking toward the company's Investor Day, scheduled for late September, as the next potential catalyst for a re-rating of the shares.

Read next

More on Stocks
Back to latest news

LATEST